VANCOUVER, July 29, 2019 /CNW/ - Geyser Brands Inc
(TSXV:GYSR) ("Geyser Brands" or the "Company") today released its
post-RTO audited financial statements for the 8-months ended
March 31, 2019 (the "Annual Financial
Statement") and accompanying management discussion and analysis.
The Annual Financial Statement represents the Company's
transitional fiscal year following the Company's RTO and change in
the fiscal year end, as further described in the Notice of Change
in Corporate Structure filed on the Company's profile on
SEDAR. Copies of the Annual Financial Statement and
corresponding management discussion and analysis are available in
full under the Company's profile on SEDAR at www.sedar.com.
MANAGEMENT COMMENTARY
Andreas
Thatcher, CEO commented, "We are pleased with our
progress in the first 8 months since completing the RTO. Our
subsidiary, 0957203 B.C. Ltd. dba
Apothecary Botanicals, through its strong management, has been
successful in bringing its facility to GMP-compliant standards for
manufacturing and processing and in obtaining Health Canada
licensing for Cultivation and Standard Processing. The
achievement of these milestones represented the foundation
necessary for Geyser to extend products into the cannabis space and
generate revenues through this highly regulated distribution
channel. Geyser took the time necessary to build its
compliance framework and is now ready to execute on its strategic
plan of building cannabis-led brands that improve everyday
lives. We are very excited about the opportunities created by
the careful investments made in the past 8 months and look forward
to capitalizing on the Canadian cannabis platform we have
built."
HIGHLIGHTS
The following is select financial
information contained in the Annual Finacial Statement, which was
prepared in accordance with IFRS as issued by the International
Accounting Standard Board and Part 1 of the Chartered Professional
Accountants of Canada Handbook – Accounting. All dollar amounts are
Canadian, unless otherwise noted.
|
For the
periods
|
|
For the
8-months
|
From Incorporation
on
|
ended
|
December 26,
2017
|
March 31,
2019
|
to July 31,
2018
|
|
|
|
Operating
Expenses
|
$1,875,244
|
$886,406
|
Operating
Loss
|
($1,875,244)
|
($886,406)
|
Other Income and
(Expense)
|
(19,706,367)
|
25,000
|
Net Loss for the
period
|
($21,581,611)
|
($861,406)
|
Loss per
share
|
|
|
Basic
|
$(2.47)
|
($0.15)
|
Diluted
|
$(2.47)
|
($0.15)
|
Weighted average
number of common shares outstanding
|
8,725,004
|
5,782,941
|
|
|
|
|
|
|
|
|
|
|
March 31,
2019
|
July 31,
2018
|
|
|
|
Total
Assets
|
$4,890,422
|
$4,504,411
|
Total
Liabilities
|
$1,047,269
|
$1,099,012
|
Total Shareholders'
Equity
|
$3,843,153
|
$3,405,399
|
ONE-TIME NON-OPERATING, NON-CASH LOSS ARISING FROM
RTO
On December 20, 2018, the
Company (formerly Kanzen Capital Corp.) completed the acquisition
of all of the issued and outstanding shares of the private company,
Geyser Management Inc. ("Geyser") and its wholly owned subsidiary
0957102 BC Ltd. ("D&G") through a reverse takeover arrangement
("RTO"). The share exchange, as further particularlized in the
Company's Filing Statement filed on the Company's profile on SEDAR,
in the RTO gave rise to a non-cash, non-operating loss of
$19,712,648 in reflecting the agreed
shareholder equity for the transaction.
The fair value of the acquired assets and liabilities assumed is
as follows:
Consideration:
|
|
10,599,717
Consideration Shares at $0.60 per share
|
$
6,359,830
|
22,500,000
Performance Shares at $0.60 per share
|
13,500,000
|
Transaction costs –
220,000 shares at $0.60 per share
|
132,000
|
Transaction costs –
150,000 warrants exercisable at $0.60
|
47,664
|
Transaction costs –
cash
|
30,975
|
Total
consideration
|
$
20,070,469
|
Net Assets
acquired:
|
|
Cash and cash
equivalents
|
$
364,537
|
GST
receivable
|
2,485
|
Prepaid
expenses
|
30,975
|
Accounts payable and
accrued liabilities
|
(40,176)
|
Total net assets
acquired
|
357,821
|
Loss on RTO
transaction
|
19,712,648
|
Total
Consideration
|
$
20,070,469
|
As a result, IFRS 2- Share-based Payment is applied to a reverse
acquisition when the accounting acquiree does not constitute a
business as defined under IFRS 3. This is common when the
transaction involves a CPC because the entity is normally a shell
company, with no operations, is looking to complete a qualifying
transaction over a specified period of time and would not meet the
definition of a business.
FINANCINGS
During the 8-month period, the Company
completed equity financing that resulted in total proceeds from
private placements of $2,015,140 and
$76,500 from the exercise of
warrants. The Company intended or intends to use the proceeds
of financings to fund the completion of capital projects, potential
acquisitions, including partnerships and joint ventures, for
research and development, to commercialize the Company's
manufacturing capabilities, and for working capital purposes.
AMENDED INTERIM FINANCIALS
The Company also announces
its filing of amended and restated Unaudited Condensed Consolidated
Interim Financial Statements for the three and six month periods
ending January 31, 2019 ("January
Interim Financials") and corresponding management discussion and
analysis for such period.
The January Interim Financials have been revised to correct the
accounting treatment of the RTO transaction where it was determined
by management, and agreed to by the Company's auditors, Buckley
Dodds LLP, that an accounting error occurred resulting in the
overstatement of the Company's assets and understatement of the
Company's net loss for the period. The share exchange in the RTO
transaction falls under the guidance of International Financial
Reporting Standard ("IFRS") 2. The RTO transaction
represented a share-based payment, resulting in a non-cash,
non-operating loss of $19,712,648
that was incorrectly accounted for in the January Interim
Financials as being the purchase of an intangible asset.
The restated January Interim Financials and the corresponding
management discussion and analysis for such period are available on
the Company's profile on SEDAR at www.sedar.com. The restated
January Interim Financials replaces and supersedes the previously
filed January Interim Financials, and the corresponding amended
management's discussion and analysis replaces and supersedes the
previously filed corresponding management's discussion and
analysis.
ABOUT GEYSER BRANDS
Geyser Brands Inc. builds
health-based hemp CBD consumer products in the nutraceutical,
cosmetics, food & beverage and pet sectors world-wide. Geyser
Brands owns a Health-Canada approved Licensed Producer (LP) in
Port Coquitlam, B.C. that holds
cultivation and processing licenses and is anticipating its R &
D and sales licenses. Geyser Brands will utilize both of its GMP-
licensed facilities in British
Columbia for the manufacturing and distribution of its hemp
and CBD-based products internationally. For more information,
visit Geyser Brands' website at www.geyserbrands.com.
On Behalf of the Board of Directors
Andreas Thatcher
Director and CEO
THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN
REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES
DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES ACT
OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE
OFFERED OR SOLD IN THE UNITED
STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE
EXEMPTION FROM REGISTRATION REQUIREMENTS.
CAUTIONARY AND FORWARD-LOOKING STATEMENTS
This news release contains forward‐looking statements and
forward‐looking information within the meaning of applicable
securities laws. These statements relate to future events or future
performance. All statements other than statements of historical
fact may be forward‐looking statements or information.
Forward‐looking statements and information are often, but not
always, identified by the use of words such as "appear", "seek",
"anticipate", "plan", "continue", "estimate", "approximate",
"expect", "may", "will", "project", "predict", "potential",
"targeting", "intend", "could", "might", "should", "believe",
"would" and similar expressions.
Forward-looking statements and information are provided for the
purpose of providing information about the current expectations and
plans of management of the Company relating to the future. Readers
are cautioned that reliance on such statements and information may
not be appropriate for other purposes, such as making investment
decisions. Since forward‐looking statements and information address
future events and conditions, by their very nature they involve
inherent risks and uncertainties. Actual results could differ
materially from those currently anticipated due to a number of
factors and risks. These include, but are not limited to, the risks
associated with the marijuana industry in general such as
operational risks in growing; competition; incorrect assessment of
the value and potential benefits of various transactions; ability
to access sufficient capital from internal and external sources;
failure to obtain required regulatory and other approvals and
changes in legislation, including but not limited to tax laws and
government regulations.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
SOURCE Geyser Brands Inc.